Our physicians participate in research trials to evaluate new, innovative treatments for the diseases we manage. This enables us to provide our patients with access to the latest options for care.
Enrolling in a trial is an important decision. If you are interested in learning more about enrolling in a trial, your physician can discuss the potential risks and benefits with you so that you can decide if you would like participate.
We are actively enrolling for the following studies. For more information about participating, please contact our Clinical Research Manager, Heather Pierce, at 856-424-5005 ext 146.
For Rheumatoid Arthritis Patients
- A Study Comparing ABT-494 to Placebo and to Adalimumab in Subjects With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate (SELECT-COMPARE)
- A Study to Compare ABT-494 Monotherapy to Methotrexate Monotherapy in Subjects With Rheumatoid Arthritis (RA) Who Have Not Previously Taken Methotrexate (SELECT-EARLY)
- Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Infliximab
- Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis